Taken together, these results validated that ALDH9A1 exerted tumor suppressor role and metabolic reprogramming role by repressing the expression of IQGAP2 and activating the AKT-mTOR-SREBP1 pathway in ccRCC. The gene discussed is ALDH9A1; the disease is nonpapillary renal cell carcinoma.